| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
139,983 |
121,922 |
$34.93M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
45,388 |
40,430 |
$429K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
8,689 |
8,044 |
$116K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
11,003 |
10,399 |
$67K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,900 |
7,351 |
$60K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,613 |
2,371 |
$49K |
| 90670 |
|
4,371 |
4,302 |
$20K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,740 |
1,052 |
$19K |
| 99499 |
|
1,230 |
1,090 |
$17K |
| 90461 |
|
536 |
341 |
$16K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
11,089 |
10,876 |
$12K |
| 90734 |
|
636 |
587 |
$10K |
| 90686 |
|
5,830 |
5,732 |
$9K |
| 90651 |
|
608 |
604 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,468 |
4,369 |
$6K |
| 90633 |
|
2,151 |
2,091 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,356 |
1,285 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
24,736 |
24,084 |
$3K |
| 90647 |
|
2,278 |
2,232 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,641 |
1,562 |
$2K |
| 90696 |
|
260 |
248 |
$1K |
| 90723 |
|
2,016 |
2,007 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
17,957 |
17,260 |
$882.65 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
16,200 |
15,957 |
$650.91 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
839 |
815 |
$552.08 |
| 90672 |
|
13 |
13 |
$292.32 |
| 90681 |
|
1,117 |
1,109 |
$50.00 |
| 90480 |
|
12 |
12 |
$40.00 |
| 92551 |
|
4,283 |
4,177 |
$0.00 |
| 36416 |
|
254 |
242 |
$0.00 |
| 90620 |
|
211 |
204 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,312 |
1,173 |
$0.00 |
| 85018 |
|
511 |
508 |
$0.00 |
| 90697 |
|
586 |
585 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,296 |
1,270 |
$0.00 |
| 90677 |
|
591 |
591 |
$0.00 |
| 90716 |
|
203 |
202 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
71 |
71 |
$0.00 |
| 90474 |
|
149 |
148 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
31 |
31 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
204 |
198 |
$0.00 |
| 90700 |
|
224 |
220 |
$0.00 |
| 83718 |
|
210 |
206 |
$0.00 |
| 99173 |
|
4,327 |
4,124 |
$0.00 |
| 90671 |
|
469 |
469 |
$0.00 |
| 81003 |
|
93 |
92 |
$0.00 |
| 90707 |
|
201 |
200 |
$0.00 |
| 90661 |
|
348 |
348 |
$0.00 |
| 83655 |
|
188 |
181 |
$0.00 |
| 90715 |
|
131 |
128 |
$0.00 |
| 90710 |
|
265 |
264 |
$0.00 |
| 90473 |
|
80 |
80 |
$0.00 |
| 87634 |
|
104 |
104 |
$0.00 |
| G9920 |
Screening performed and negative |
728 |
681 |
$0.00 |
| 3725F |
|
28 |
27 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
242 |
242 |
$0.00 |
| 99177 |
|
24 |
24 |
$0.00 |